Please assess the completion status of the following clinical trial:

Trial Title: Effects of SEvoflurane on Gas Exchange and Inflammation in Patients With ARDS (SEGA Study)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with criteria for moderate to severe ARDS since less than 24 hours (~* Informed consent~Exclusion Criteria:~* Suspected or proven intracranial hypertension~* Midazolam, sevoflurane or cisatracurium allergy~* Medical history of malignant hyperthermia~* Severe liver failure~* Chemotherapy treatment in the last month~* Severe neutropenia (\< 0.5 G/l)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- conventional group (Type: EXPERIMENTAL): a conventional group, in which intravenous sedation with midazolam will be administered
- sevoflurane group (Type: EXPERIMENTAL): a sevoflurane group, in which patients will inhale sevoflurane during a 48 hour-period, through dedicated devices

Based on this trial design, predict the completion outcome and termination type (if applicable).